Primary resistance to integrase strand-transfer inhibitors in Europe

Autor: Casadellà, M., van Ham, P. M., Noguera-Julian, M., van Kessel, A., Pou, C., Hofstra, L. M., Santos, J. R., Garcia, F., Struck, D., Alexiev, I., Bakken Kran, A. M., Hoepelman, A. I., Kostrikis, L. G., Somogyi, S., Liitsola, K., Linka, M., Nielsen, C., Otelea, D., Paraskevis, D., Poljak, M., Puchhammer-Stöckl, E., Staneková, D., Stanojevic, M., van Laethem, K., Zidovec Lepej, S., Clotet, B., Boucher, C. A. B., Paredes, R., Wensing, A. M. J.

Publikováno v: RIUVic. Repositorio Institucional de la Universidad de Vic
instname
Casadellà, M, van Ham, P M, Noguera-Julian, M, van Kessel, A, Pou, C, Hofstra, L M, Santos, J R, Garcia, F, Struck, D, Alexiev, I, Bakken Kran, A M, Hoepelman, A I, Kostrikis, L G, Somogyi, S, Liitsola, K, Linka, M, Otelea, D, Paraskevis, D, Poljak, M, Puchhammer-Stöckl, E, Staneková, D, Stanojevic, M, Van Laethem, K, Zidovec Lepej, S, Clotet, B, Boucher, C A B, Paredes, R, Wensing, A M J, SPREAD programme & Pedersen, C 2015, ' Primary resistance to integrase strand-transfer inhibitors in Europe ', Journal of Antimicrobial Chemotherapy, vol. 70, no. 10, pp. 2885-2888 . https://doi.org/10.1093/jac/dkv202
Journal of Antimicrobial Chemotherapy, 70(10), 2885. Oxford University Press
Journal of Antimicrobial Chemotherapy, 70(10), 2885-2888. Oxford University Press
Journal of antimicrobial chemotherapy, 70(10), 2885-2888. Oxford University Press

Objectives: The objective of this study was to define the natural genotypic variation of the HIV-1 integrase gene across Europe for epidemiological surveillance of integrase strand-transfer inhibitor (InSTI) resistance. Methods: This was a multicentr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c80687860c7a8098660e120d54167e6f
https://doi.org/10.1093/jac/dkv202

The burden of transmitted drug resistance in clinical practice in Europe is increasing over time despite a stable prevalence

Autor: Hofstra, M, Sauvageot, N, Albert, J, Alexiev, I, Garcia, F, Struck, D, Vercauteren, J, Van de Vijver, D, Åsjö, B, Balotta, C, Beshkov, D, Camacho, R, Coughlan, C, Griskevicius, A, Hamouda, O, Horban, A, Kolupajeva, T, Kostrikis, L, Kücherer, C, Liitsola, K, Linka, M, Mor, O, Nielsen, C, Otelea, D, Paraskevis, D, Paredes, D, Poljak, Mario, Puchhammer-Stöckl, E, Somnerborg, A, Stanekova, D, Stanojević, M, Van Vaethem, K, Van Wijngaerclen, E, Židovec Lepej, Snježana, Bucher, C, Schmit, JC, Wensing, A.

Objectives: In the last decade, we showed that 1 in 10 patients newly diagnosed with HIV-1 in Europe is infected with a virus that harbours transmitted drug resistance mutations (TDR). We estimated the proportion and total number of HIV-1 diagnoses w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::d7864f1a876b5311c7d0fd389267e5c3
https://www.bib.irb.hr/669380

P72 - Re-analysis of unassigned hepatitis C virus (HCV) strain CYHCV025: evidence of a highly divergent lineage within genotype 1

Autor: Oikonomopoulou, M., Demetriou, V., Kostrikis, L., Paraskevis, D.

Publikováno v: In Journal of Virus Eradication May 2016 2 Supplement 1:44-44

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.